Mihaela Gabriela Bontea

Dr. Mihaela Gabriela Bontea

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2023 in Medicina
Verified
Journal Article
Open access
PDF file
MBMihaela Gabriela Bontea
Mihaela Gabriela Bontea
EBErika Bimbo-Szuhai
Erika Bimbo-Szuhai
IMIULIA CODRUTA MACOVEI
IULIA CODRUTA MACOVEI
Paula MaghiarPaula Maghiar
Paula Maghiar
MSMircea Sandor
Mircea Sandor
AHAnca Carmen Huniadi
Anca Carmen Huniadi
Background and Objectives: This study aimed to explore the preoperative factors related to early mobilization and length of stay (LOS) after total hip arthroplasty and the benefits of the anterior approach over the traditional lateral approach. Materials and Methods: Every patient benefits from information regarding details of the surgery approach, possible intra, and postoperative complications, post-operator medical care, and steps in the early mobilization protocol. The patient underwent a pre-anesthetic evaluation, was checked for preoperatory vital function, and was reevaluated for mobilization at 6, 12, 24, 36, 48, and 96 h after total hip arthroplasty using the anterior versus lateral approach. Results: The result of the statistical calculations indicates the independent negative risk factors for reaching the mobilization target: age with a coefficient of −0.046, p = 0.0154 and lateral approach with a relative risk of 0.3802 (95% CI: 0.15–0.90), p = 0.0298. Statistical data concerning the length of stay (LOS) showed significant differences in the total days spent in the hospital. The patients who were operated on using the lateral approach presented a higher body mass index than those with the anterior approach, but this difference did not reach the threshold of statistical significance. Conclusions: In our study, patient mobilization is crucial to reduce LOS.

1 January 2023 in Annals of Pharmacy Education, Safety, and Public Health Advocacy
Verified
Journal Article
Open access
PDF file
DTDan Alexandru Tătaru
Dan Alexandru Tătaru
MBMihaela Gabriela Bontea
Mihaela Gabriela Bontea
CMClaudiu Matei
Claudiu Matei
CBCălin Buzlea
Călin Buzlea
As medical science continually evolves, continuing education programs play an important role in keeping healthcare professionals updated with the latest advancements. In response to this need, the present review aimed to examine the common and effective teaching methods used in continuing education, identifying strategies that promote sustainable learning and improve educational outcomes. This review covers literature published between 2000 and 2023, sourced from databases such as Google Scholar, Elsevier ISI (Web of Science), and Scopus, using keywords including "educational method," "continuing education," and "common method of teaching." The findings highlight that teaching methods are among the most influential factors in the success of continuing education programs. Numerous studies emphasize the pivotal role of instructional strategies in facilitating effective learning for healthcare professionals. While traditional methods remain relevant, the integration of innovative approaches-such as group discussions, problem-solving techniques, collaborative models, clinical education, elearning, simulation-based training, and evidence-based medicine-significantly contributes to lasting learning outcomes. Employing a combination of these methods can motivate ongoing professional development and support long-term competence in healthcare delivery.

16 November 2025 in Medicina
Verified
Journal Article
Open access
PDF file
GPGeorgiana Maria Popa
Georgiana Maria Popa
AAAlina Simona Abu-Awwad
Alina Simona Abu-Awwad
Ahmed Abu-AwwadAhmed Abu-Awwad
Ahmed Abu-Awwad
CMCarmen-Ioana Marta
Carmen-Ioana Marta
EBErika Bimbo-Szuhai
Erika Bimbo-Szuhai
MBMihai Octavian Botea
Mihai Octavian Botea
Background and Objectives: Effective perioperative pain management remains a key goal of enhanced recovery protocols, especially in minimally invasive urologic surgery, where optimizing comfort while limiting opioid exposure is essential. Intravenous lidocaine has gained attention for its multimodal analgesic and anti-inflammatory properties, yet evidence in robotic prostatectomy remains limited. This study evaluated whether intraoperative lidocaine infusion was associated with lower early postoperative pain scores and reduced opioid use in patients undergoing robotic-assisted radical prostatectomy. Materials and Methods: A retrospective, single-center analysis was conducted at Pelican Clinical Hospital, Oradea, Romania, including 112 patients operated on between January 2020 and December 2023. All procedures were performed by the same surgical and anesthetic teams using standardized ERAS-based protocols. Patients were divided into two groups: the Lidocaine Group (LG, n = 51), who received a bolus of 1.5 mg/kg lidocaine followed by an infusion of 1.5 mg/kg/h during surgery, and the Control Group (CG, n = 61), who received standard anesthesia without lidocaine. Postoperative pain was measured using the visual analog scale (VAS) at 0, 4, 12, and 24 h, and opioid use was converted into morphine milligram equivalents (MME). Secondary outcomes included time to ambulation, gastrointestinal recovery, oral intake, hospital stay, and complications. Results: Pain intensity was significantly lower in the lidocaine group at 4 h postoperatively (VAS 3.5 ± 1.1 vs. 4.3 ± 1.3; p = 0.01), with similar scores later. Total opioid use was reduced by about 18% in the lidocaine group (25.7 ± 9.4 vs. 31.2 ± 10.5 MME; p = 0.03). Recovery parameters and complication rates were comparable between groups, and no lidocaine-related adverse events were recorded. Conclusions: Intraoperative intravenous lidocaine was associated with lower early postoperative pain scores and reduced opioid requirements after robotic-assisted radical prostatectomy without affecting recovery or safety. Its favorable profile and low cost support its inclusion as a practical adjunct in multimodal analgesia within ERAS pathways.

Verified
Journal Article
Open access
PDF file
EBErika Bimbo-Szuhai
Erika Bimbo-Szuhai
MBMihai Octavian Botea
Mihai Octavian Botea
DRDANA DIANA ROMANESCU
DANA DIANA ROMANESCU
BCBeiusanu Corina
Beiusanu Corina
GGGabriela Maria Gavrilas
Gabriela Maria Gavrilas
IMIULIA CODRUTA MACOVEI
IULIA CODRUTA MACOVEI
(1) Background: Our study aims to investigate the utility of inflammatory factors as prognostic indicators for disease severity and mortality in COVID-19 patients admitted to the Intensive Care Unit (ICU) Department of Pelican Clinical Hospital Oradea Romania. While elevated white blood cell (WBC) levels are associated with COVID-19 severity and mortality, they may not effectively predict the risk of death; (2) Methods: In our ICU department, we conducted assessments on the 10th and 14th days of COVID-19 patients’ hospitalization, measuring the following markers: C-reactive protein (CRP) levels, procalcitonin (PCT) levels, granulocytes/lymphocytes (G/L) ratios, ferritin levels, age, and obesity status. We included a total of 209 eligible COVID-19 patients in the final analysis. Our goal was to identify biomarkers that could quickly identify high-risk patients with a potential for disease progression and mortality; (3) Results: Our study (a retrospective, single-center observational cohort study) demonstrated statistically significant differences in predicting mortality and disease severity based on G/L ratio (p < 0.0001), PCT (p < 0.0002), CRP (p < 0.0001), ferritin (p < 0.0001), age (p < 0.0001), and obesity (p < 0.0001); (4) Conclusions: Having a G/L ratio exceeding 20 units, along with elevated levels of PCR, PCT, and ferritin in older and obese patients on the 3rd day of ICU admission, represents significant risk factors for in-hospital mortality in severe COVID-19 patients.

28 December 2025 in Medicina
Verified
Journal Article
Open access
PDF file
GPGeorgiana Maria Popa
Georgiana Maria Popa
AAAlina Simona Abu-Awwad
Alina Simona Abu-Awwad
Ahmed Abu-AwwadAhmed Abu-Awwad
Ahmed Abu-Awwad
CMCarmen-Ioana Marta
Carmen-Ioana Marta
EBErika Bimbo-Szuhai
Erika Bimbo-Szuhai
MBMihai Octavian Botea
Mihai Octavian Botea
Background and Objectives: Surgical stress during robotic-assisted radical prostatectomy (RARP) elicits a measurable systemic inflammatory response despite the minimally invasive approach. Intravenous lidocaine has been increasingly investigated for its potential anti-inflammatory, analgesic, and immunomodulatory benefits, but evidence in robotic urologic oncology remains limited. This study aimed to evaluate whether intraoperative lidocaine infusion attenuates postoperative inflammation, improves analgesic outcomes, and accelerates early recovery following RARP. Materials and Methods: This prospective non-randomized observational study included 80 patients undergoing elective RARP, divided into a Lidocaine Group (n = 40) receiving an intraoperative bolus and continuous infusion, and a Control Group (n = 40) receiving standard anesthesia without lidocaine. Serum IL-6, TNF-α, CRP, and fibrinogen were measured at baseline, end of surgery, and 24 h postoperatively. Postoperative pain scores, opioid consumption, gastrointestinal recovery, ambulation, and length of stay were recorded. Statistical analyses included repeated-measures ANOVA, correlation testing, and between-group comparisons. Results: Baseline characteristics were similar between groups. At 24 h postoperatively, lidocaine administration was associated with a significantly attenuated inflammatory response, with lower levels of IL-6 (45.7 ± 10.8 vs. 68.9 ± 12.6 pg/mL, p < 0.01) and TNF-α (20.5 ± 5.1 vs. 27.2 ± 6.4 pg/mL, p < 0.01) compared with controls. Patients receiving lidocaine reported lower postoperative pain scores and required significantly less opioid analgesia, with a total 24 h consumption of 8.9 ± 3.4 vs. 14.8 ± 5.2 mg morphine milligram equivalents (p < 0.001). Lidocaine was also associated with faster recovery, including earlier oral intake and a shorter length of hospital stay (2.9 ± 0.7 vs. 3.6 ± 0.9 days, p = 0.003). No lidocaine-related adverse events were observed. Conclusions: In this prospective observational study, intraoperative intravenous lidocaine was associated with attenuated early postoperative inflammation, improved analgesic outcomes, and enhanced early recovery following RARP. These findings support the potential role of intravenous lidocaine as a safe adjunct in multimodal perioperative management; however, given the non-randomized observational design, causal inferences should be interpreted with caution. Further randomized controlled trials are warranted to confirm causality and to validate long-term clinical and mechanistic effects. Potential residual confounding inherent to the observational design should be considered when interpreting these findings.

25 February 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
EBErika Bimbo-Szuhai
Erika Bimbo-Szuhai
MBMihai Octavian Botea
Mihai Octavian Botea
Harrie Toms JohnHarrie Toms John
Harrie Toms John
ADAdela Bostan Danciu
Adela Bostan Danciu
PRPirvan Titus Razvan
Pirvan Titus Razvan
IMIULIA CODRUTA MACOVEI
IULIA CODRUTA MACOVEI
Background and Objectives: We have conducted a retrospective study on patients who underwent total hip arthroplasty. We analyzed spinal anesthesia hemodynamic effects for optimal spinal anesthesia-induced hypotension (SAIH) management. This study explored the perioperative factors related to spinal anesthesia-induced hypotension and the dose of Ephedrine used to ensure hemodynamic stability. Materials and methods: Every patient benefits from information regarding details of the surgery approach and possible intraoperative hemodynamic variations induced by spinal anesthesia (SA). Three hundred twenty-nine patients were included in this study. We compared two groups based on the type of SA: bupivacaine with morphine (group M) and bupivacaine with fentanyl (group F). Results: We observed that the amount of ephedrine dose used correlates with high blood pressure (HBP) in 19 % of cases and with age in 44,1%. Conclusion: Ephedrine use for hemodynamic stability is the key to ensuring safer and more effective perioperative care.